Project Inform
   

Anti-HIV medications, by class

Entry and fusion inhibitors

Fuzeon (enfuvirtide, T20)
Selzentry (maraviroc)

Integrase inhibitors

Isentress (raltegravir)

Multi-class drugs

Atripla (efavirenz + tenofovir + emtricitabine)

Nucleoside/nucleotide reverse
transcriptase inhibitors (NRTIs)

Combivir (zidovudine/AZT + lamivudine/3TC)
Emtriva (emtricitabine, FTC)
Epivir (lamivudine, 3TC)
Epzicom (abacavir + lamivudine)
Retrovir (zidovudine, AZT)
Trizivir (abacavir + zidovudine + lamivudine)
Truvada (tenofovir + emtricitabine/FTC)
Videx & Videx EC (didanosine, ddI)
Viread (tenofovir)
Zerit (stavudine, d4T)
Ziagen (abacavir)

Non-nucleoside reverse
transcriptase inhibitors (NNRTIs)

Intelence (etravirine)
Rescriptor (delavirdine)
Sustiva (efavirenz)
Viramune (nevirapine)

Protease inhibitors (PIs)

Agenerase (amprenavir)
Aptivus (tipranavir)
Crixivan (indinavir)
Invirase (saquinavir)
Kaletra (lopinavir + ritonavir)
Lexiva (fosamprenavir)
Norvir (ritonavir)
Prezista (darunavir)
Reyataz (atazanavir)
Viracept (nelfinavir)

 
     
 

© 2009 Project Inform  1375 Mission Street,  San Francisco, CA 94103  415-558-8669
National HIV/AIDS Treatment Hotline 1-800-822-7422 (415-558-9051 local/int'l) 10a-4p Mon-Fri PST